Drug Co. Investors Settle Clinical Trial Suit For $2.3M
By Sydney Price · October 2, 2023, 7:50 PM EDT
Investors of biotherapeutics company Kiromic BioPharma Inc. asked a New York federal judge to initially approve a $2.3 million settlement in a suit accusing the company of touting prospects for two...
To view the full article, register now.